PAPER Beyrent E, Gomez G
SEARCH RESULTS
1216 RESULTS
PAPER Bartoletti M, Bosco DA, Da Cruz S, Lagier-Tourenne C, Liachko N, Markmiller S, Webster KM, Wharton KA
Phenotypic Suppression of ALS/FTD-Associated Neurodegeneration Highlights Mechanisms of Dysfunction.
J Neurosci. 2019 Oct 16;39(42):8217-8224. PubMed: 31619490PAPER Pande M, Srivastava R
Molecular and clinical insights into protein misfolding and associated amyloidosis.
Eur J Med Chem. 2019 Dec 15;184:111753. Epub 2019 Oct 7 PubMed: 31622853PAPER Rani K, Mukherjee R, Singh E, Kumar S, Sharma V, Vishwakarma P, Bharti PS, Nikolajeff F, Dinda AK, Goyal V, Kumar S
Neuronal exosomes in saliva of Parkinson's disease patients: A pilot study.
Parkinsonism Relat Disord. 2019 Oct;67:21-23. Epub 2019 Sep 9 PubMed: 31621600PAPER Grimaldi S, Boucekine M, Witjas T, Fluchère F, Renaud M, Azulay JP, Guedj E, Eusebio A
Multiple System Atrophy: Phenotypic spectrum approach coupled with brain 18-FDG PET.
Parkinsonism Relat Disord. 2019 Oct;67:3-9. Epub 2019 Sep 9 PubMed: 31621603PAPER Cuperlovic-Culf M, Badhwar A
Recent advances from metabolomics and lipidomics application in alzheimer's disease inspiring drug discovery.
Expert Opin Drug Discov. 2020 Mar;15(3):319-331. Epub 2019 Oct 16 PubMed: 31619081PAPER Manni R, Cremascoli R, Perretti C, De Icco R, Picascia M, Ghezzi C, Cerri S, Sinforiani E, Terzaghi M
Evening melatonin timing secretion in real life conditions in patients with Alzheimer disease of mild to moderate severity.
Sleep Med. 2019 Nov;63:122-126. Epub 2019 May 31 PubMed: 31622953PAPER Lamotte G, Holmes C, Wu T, Goldstein DS
Long-term trends in myocardial sympathetic innervation and function in synucleinopathies.
Parkinsonism Relat Disord. 2019 Oct;67:27-33. Epub 2019 Sep 16 PubMed: 31621602PAPER Stephen TL, Tamagnini F, Piegsa J, Sung K, Harvey J, Oliver-Evans A, Murray TK, Ahmed Z, Hutton ML, Randall A, O'Neill MJ, Jackson JS
Imbalance in the response of pre- and post-synaptic components to amyloidopathy.
Sci Rep. 2019 Oct 16;9(1):14837. PubMed: 31619689PAPER Matsura T
Protective Effect of Tocotrienol on In Vitro and In Vivo Models of Parkinson's Disease.
J Nutr Sci Vitaminol (Tokyo). 2019;65(Supplement):S51-S53. PubMed: 31619646PAPER Yoshida KI, Ishikawa S
Production of scyllo-Inositol: Conversion of Rice Bran into a Promising Disease-Modifying Therapeutic Agent for Alzheimer's Disease.
J Nutr Sci Vitaminol (Tokyo). 2019;65(Supplement):S139-S142. PubMed: 31619615PAPER Parker TD, Cash DM, Lane CA, Lu K, Malone IB, Nicholas JM, James SN, Keshavan A, Murray-Smith H, Wong A, Buchanan SM, Keuss SE, Sudre CH, Modat M, Thomas DL, Crutch SJ, Richards M, Fox NC, Schott JM
Hippocampal subfield volumes and pre-clinical Alzheimer's disease in 408 cognitively normal adults born in 1946.
PLoS One. 2019;14(10):e0224030. Epub 2019 Oct 17 PubMed: 31622410PAPER Limboonreung T, Tuchinda P, Chongthammakun S
Chrysoeriol mediates mitochondrial protection via PI3K/Akt pathway in MPP+ treated SH-SY5Y cells.
Neurosci Lett. 2020 Jan 1;714:134545. Epub 2019 Oct 14 PubMed: 31622648PAPER Singer E, Walter C, Fabbro D, Rageot D, Beaufils F, Wymann MP, Rischert N, Riess O, Hillmann P, Nguyen HP
Brain-penetrant PQR620 mTOR and PQR530 PI3K/mTOR inhibitor reduce huntingtin levels in cell models of HD.
Neuropharmacology. 2020 Jan 1;162:107812. Epub 2019 Oct 14 PubMed: 31622602PAPER Calvin CM, Wilkinson T, Starr JM, Sudlow C, Hagenaars SP, Harris SE, Schnier C, Davies G, Fawns-Ritchie C, Gale CR, Gallacher J, Deary IJ
Predicting incident dementia 3-8 years after brief cognitive tests in the UK Biobank prospective study of 500,000 people.
Alzheimers Dement. 2019 Dec;15(12):1546-1557. Epub 2019 Oct 13 PubMed: 31619348Current Filters
- Date Range : Sep 2019 to Oct 2019 x